Eagle Pharmaceuticals, Inc. (EGRX)
NGM · Common · CUSIP 269796108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for EGRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
269796108
Market Cap
Small Cap
IPO
2/12/2014 · $15.00/share
Business: Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway. The company develops products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products.

Company Contact

CEO
Michael Graves
CFO
Rrian Cahill
Headquarters
50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ 07677
Phone
201-326-5300
Investor Relations
Lisa M. Wilson, In-Site Communications · 212-452-2793 · lwilson@insitecony.com
General Email
investors@eagleus.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »